The net 5-year survival rate for patients suffering from liver cancer is less then 20 percent and the number of cases is rapidly increasing in Canada. Unfortunately, currently available oral chemotherapies can only extend median survival by 3 – 4 months making the development of new and effective drug treatments critical. The proposed study aims […]
Read More